Early HER2+ early breast cancer: APHINITY follow-up confirms DFS benefit of add-on pertuzumabMarch 10, 2021Breast Cancer
HER2+ metastatic breast cancer: Pyrotinib+capecitabine boosts PFS in PHOEBEMarch 10, 2021Breast Cancer
Genetic testing for breast and ovarian cancer: What has changed and what still needs to change?March 5, 2021Breast Cancer
Latest Treatment Options in HR+/HER2- Advanced Breast Cancer in Postmenopausal WomenMarch 1, 2021Breast CancerMetastatic Breast Cancer
PET predicts response to endocrine therapy in ER+ breast cancerFebruary 19, 2021Breast CancerMetastatic Breast Cancer
